Low nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression. - Wikidata - awgldk - TriplyDB

Low nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression.

Low nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression.

http://www.wikidata.org/entity/Q37228204

about

Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice EGF receptor deletion in podocytes attenuates diabetic nephropathy.ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy.Interaction of the EGF Receptor and the Hippo Pathway in the Diabetic Kidney.Excess HB-EGF, which promotes VEGF signaling, leads to hydrocephalus The epidermal growth factor receptor pathway in chronic kidney diseases.Role of TGF-alpha in the progression of diabetic kidney disease.Specific endothelial heparin-binding EGF-like growth factor deletion ameliorates renal injury induced by chronic angiotensin II infusion.Can we fight chronic kidney disease by targeting endothelial HB-EGF?High Glucose Up-regulates ADAM17 through HIF-1α in Mesangial Cells.Selective activation of epidermal growth factor receptor in renal proximal tubule induces tubulointerstitial fibrosis.

P2860

Q34412951-86445575-D71C-497B-A45B-3531A3E163F5 Q35550573-1FA6D809-9492-4BE2-9732-177A0A83699A Q36542481-C4941EDE-1387-46FF-9F21-118FB25042F2 Q36944680-10DAF5BF-9439-43A6-BF3D-51B18A1C7859 Q36950613-8F7B8CAB-7AEB-4ACB-9779-8FB8CAEA7315 Q38885079-334BB762-E379-4C69-B6EB-180386B6087B Q40312801-67D392D1-35C0-43FA-96C4-75ECBBD9D314 Q41630808-CF8C47EF-B0E0-4813-A413-4C969770E932 Q41776022-FFABD6CE-C32F-4BE8-B59D-E8BDE425D337 Q41849322-99A31F0F-5364-417A-B5C8-BD70B8988D49 Q47852809-0B8A7074-F6AF-41B0-A6E3-ABB35C3C094C

P2860

Low nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression.

http://www.wikidata.org/entity/Q37228204

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Low nitric oxide bioavailabili ...... like growth factor expression.

@en

Low nitric oxide bioavailabili ...... like growth factor expression.

@nl

type

label

Low nitric oxide bioavailabili ...... like growth factor expression.

@en

Low nitric oxide bioavailabili ...... like growth factor expression.

@nl

prefLabel

Low nitric oxide bioavailabili ...... like growth factor expression.

@en

Low nitric oxide bioavailabili ...... like growth factor expression.

@nl

P1433

Q37228204-668CAD06-01B3-484C-A8C3-C9FED69937AF

P1476

Q37228204-33AB4202-B5E3-4233-8C72-811232EEFA08

P2093

Q37228204-04FA9C02-FCEB-4586-ACD1-1D7A42A95A0A

Q37228204-0D047AA1-BC5A-450B-89AC-3287671F3FE6

Q37228204-28F646F5-8FD4-4672-9ED2-A4FB505AC4A9

Q37228204-6C884F53-4110-4D65-B855-DD2033682AE6

Q37228204-9F8365CC-C512-4B67-B02F-7D2DD58B027A

Q37228204-B5FA92E1-F0F0-4B75-B740-7A6320D63556

Q37228204-C34E7CD3-02B1-49FE-B67F-96DF7664322C

Q37228204-C8443A93-75FB-4C19-A88C-C651F459FB41

Q37228204-CF1013E7-853C-48A1-8B05-471FA4E1A998

P2860

Q37228204-0E7187C9-59A9-4288-8C6B-09ECE942D2E4

Q37228204-27712CF4-E128-41EA-8933-203F6C79169F

Q37228204-2D06D01E-1862-4B3E-B10A-FE975A770EBF

Q37228204-3A21C49C-F964-4CDA-B8B0-80916806F918

Q37228204-42A66818-5FEF-4D3B-91A4-589D60F3D9A8

Q37228204-4DEC36D7-919B-40C8-8EEC-CD5C7379BBE2

Q37228204-51B9C85A-3AD6-476B-9088-BA740A06F0C7

Q37228204-599CC65F-83B9-425C-B1F2-19B9D30A6499

Q37228204-623F35C1-FA8C-4F73-AF20-B9904DF9B20F

Q37228204-65FF5BC1-52CE-45D2-9111-AEF9D0BC65A8

P2888

Q37228204-C121D554-550B-409D-A190-74B353707C36

P304

Q37228204-EFACE236-9B93-4E63-ACE9-3D885DE9B7A0

P31

Q37228204-3F6D7FDE-5D7D-4DDD-AAAF-D9FCDF32A223

P356

Q37228204-DD6DBC2F-B11D-4C94-80F1-23641354E338

P407

Q37228204-0E4B6CDB-CB06-4BE9-8A8E-80D77CE1F478

P433

Q37228204-7BC19594-9B00-43F3-B87D-B5B1047A1719

P478

Q37228204-8684C9EE-B2CD-44BE-A71E-070BE2ECF470

P577

Q37228204-DD52F73A-0911-447C-8CA2-42F6D9E8A519

P5875

Q37228204-94D73A67-645D-4E8B-A706-E597B39957FB

P6179

Q37228204-3CD8B85B-608D-4E8E-890B-2D055CEEE353

P698

Q37228204-8B753AC3-64B6-43E6-A456-68D600E60062

P932

Q37228204-C51572A5-4B1B-44D0-B305-6C51EF7CAF2F

P356

P1433

Kidney International

P1476

Low nitric oxide bioavailabili ...... like growth factor expression.

@en

P2093

Agnes B Fogo

http://www.w3.org/2001/XMLSchema#string

Aihua Bian

http://www.w3.org/2001/XMLSchema#string

Fenghua Zeng

http://www.w3.org/2001/XMLSchema#string

Haichun Yang

http://www.w3.org/2001/XMLSchema#string

Huifang Cheng

http://www.w3.org/2001/XMLSchema#string

Raymond C Harris

http://www.w3.org/2001/XMLSchema#string

Suwan Wang

http://www.w3.org/2001/XMLSchema#string

Tomoki Miyazawa

http://www.w3.org/2001/XMLSchema#string

Xiaofeng Fan

http://www.w3.org/2001/XMLSchema#string

P2860

Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel

Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing

Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization.

Heparin-binding EGF-like growth factor: a juxtacrine growth factor.

Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques.

Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a possible ligand for interaction with blastocyst EGF-receptor in implantation.

Involvement of glycation and oxidative stress in diabetic macroangiopathy.

Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells. The involvement of reactive oxygen species formation and a possible implication for atherogene

P2888

P304

1176-1188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/KI.2013.214

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237844012

http://www.w3.org/2001/XMLSchema#string

P6179

1013307314

http://www.w3.org/2001/XMLSchema#string

P698

23760291

http://www.w3.org/2001/XMLSchema#string

P932

3796048

http://www.w3.org/2001/XMLSchema#string